Mitral Paravalvular Leak: Clinical Implications, Diagnosis and Management.
Ignacio Cruz-GonzalezPablo José Antúnez MuiñosSergio Lopez-TejeroPedro L SanchezPublished in: Journal of clinical medicine (2022)
Paravalvular leak incidence after mitral surgical replacement ranges from 7% to 17%. Between 1% and 5% of these are clinically significant. Large PVLs can cause important clinical manifestations such as heart failure or haemolysis. Current guidelines consider that surgical reparation is the gold-standard therapy in symptomatic patients with paravalvular leak. However, these recommendations are based in non-randomized observational registries. On the other hand, transcatheter paravalvular leak closure has shown excellent results with a low rate of complications, and nowadays it is considered the first option in selected patients in some experienced centres. In this review, we summarize the clinical manifestations, diagnosis, procedural details, and results of transcatheter mitral PVL closure.
Keyphrases
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- mitral valve
- left ventricular
- ejection fraction
- heart failure
- left atrial
- end stage renal disease
- aortic valve
- risk factors
- newly diagnosed
- chronic kidney disease
- clinical practice
- atrial fibrillation
- open label
- randomized controlled trial
- stem cells
- cardiac resynchronization therapy
- cross sectional
- clinical trial
- phase iii
- patient reported outcomes
- bone marrow
- smoking cessation
- replacement therapy